Latest News Archive
Please select Category, Year, and then Month to display items
03 October 2018
|
Story UFS
|
Photo Katlego Sekele
Students engaged authorities and Student Affairs
representatives on sexual and gender-based matters.
Do you know enough about the Sexual Harassment, Sexual Misconduct and Sexual Violence policy adopted by the university in June 2018? The Office for Gender and Sexual Equity (GSE) at the University of the Free State (UFS) hosted a dialogue on the role of the institution in matters of sexual and gender-based violence and addressing issues surrounding sexual violations.
Developments such as the countrywide #TotalShutdown: Intersectional Women’s March Against Gender-based Violence last month serve as proof of the dire need for issues surrounding sexual violations to inform policies and active safety measures.
Policy purpose
According to the policy, the objectives are to create a safe and enabling environment, establish a common understanding of what constitutes sexual harassment, sexual misconduct and sexual violence, provide applicable and accurate information, ensure that victims receive the necessary support, clearly outline disciplinary procedures for perpetrators, and clarify institutional accountability.
Student’s take on solutions
Tammy Fray, a member of the Student Representative Council, who formed part of the panel at the discussion, says the policy is not a one-stop-shop solution. “The policy is a guiding document. We have to then use it to inform activist work. We cannot always put the onus on policies and codes of conducts to solve problems. However it is our responsibility within this academic space to come up with solutions that enhance the way the policy works.”
Be informed about the policy
It is important to understand the stipulations of the policy in order to make full use of it. Geraldine Lengau, Officer at the GSE said: “It’s important that students know that the institution is not operating in silos but that their demands have been heard and the institution has acknowledged that there is a need for the policy to be adopted. It also makes the process of reporting better with the assistance of the Sexual Assault Response Team coordinator.”
Haemophilia home infusion workshop
2017-12-17
Parents receive training for homecare of their children with haemophilia.
Photo Supplied
Caregivers for haemophilia patients, and patients themselves from around the Free State and Northern Cape attended a home infusion workshop held by the Clinical Skills unit in the Faculty of Health Sciences in July 2017. “It felt liberating and I feel confident to give the factor to my son correctly,” said Amanda Chaba-Okeke, the mother of a young patient, at the workshop. Her son, also at the workshop, agreed. “It felt lovely and good to learn how to administer factor VIII.”
Clinical skills to empower parents and communities
There were two concurrent sessions: one attended by doctors from the Haemophilia Treatment Centre, and the other attended by community members including factor VIII and XI recipients, caregivers and parents. The doctors’ meeting was shown informative videos and demonstrations on how to administer the newly devised factor VII and XI kit, and discussed the pressing need for trained nurses at local clinics. Dr Jaco Joubert, a haematologist, made an educational presentation to the community members.
The South African Haemophilia Foundation was represented by Mahlomola Sewolane, who gave a brief talk about the role of the organisation in relation to the condition. Meanwhile, procedural training in the simulation laboratory involved doctors and nurses helping participants to learn the procedures by using mannequins and even some volunteers from among the patients.
A medical condition causing serious complications
Haemophilia is a medical condition in which the ability of the blood to clot is severely impaired, even from a slight injury. The condition is typically caused by a hereditary lack of a coagulation factor, most often factor VIII. Usually patients must go through replacement therapy in which concentrates of clotting factor VIII (for haemophilia A) or clotting factor IX (for haemophilia B) are slowly dripped or injected into the vein, to help replace the clotting factor that is missing or low. Patients have to receive this treatment in hospital.